Safety study of a glowing dye for brain tumor surgery
Part of Cancer clinical trials.
This trial tests a dye (SBK2-ICG) that makes brain tumors glow during surgery. It's a safety study to see if the dye is safe and works well, which might help surgeons remove brain tumors more completely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a brain tumor that has not been treated yet (no prior surgery, radiation, or chemotherapy for it).
- The tumor must be in the upper part of the brain (supratentorial), not in the lower areas.
- You and your surgeon must already be planning to remove the tumor with surgery.
- You need to be in reasonably good health (able to carry out daily activities) and able to have an MRI scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special imaging device (GLOW400) used during brain surgery for high-grade glioma. The device works with a fluorescent dye (5-ALA) to help the surgeon see the tumor more clearly, which may improve removal of the tumor while protecting healthy brain tissue.
This trial tests a new kind of PET scan that uses a special tracer (Zr-89 crefmirlimab berdoxam) to help doctors see brain tumors more clearly before surgery. If you are scheduled to have your brain tumor removed, this scan may give your surgeon extra information to guide the operation.
This trial tests how well different doses of a new drug, BI 764532, are tolerated by people with a specific type of brain tumor (glioma) that has not responded to standard treatments. The drug targets a protein on the tumor cells, which may help slow tumor growth.
This trial tests a dye that makes brain tumor tissue glow under a special light during surgery, helping the surgeon see and remove more of the tumor while sparing healthy brain. It is for people with newly diagnosed high-grade glioma (a fast-growing brain tumor) who are scheduled for their first surgery to remove the tumor.
This trial compares two surgical techniques for removing malignant brain tumors: one using a special dye (5-ALA) that makes tumor cells glow under a blue light, versus the standard white light surgery. The goal is to see if the dye-guided approach helps surgeons remove more of the tumor safely.
This trial tests a drug called 5-ALA that makes brain tumor cells glow under a special light during surgery. This helps surgeons see and remove more of the tumor safely, potentially improving outcomes for children with high-grade brain tumors.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.